HDFC Pharma and Healthcare Fund vs NIPPON INDIA MULTI CAP FUND (Multi Cap Fund - An Open Ended Equity Scheme Investing Across Large Cap, Mid Cap, Small Cap Stocks)

Portfolio Overlap Analysis · HDFC vs Nippon

5.3%
Low Overlap
8 common stocks · Rank #27822 of 28,292 pairs

Common Holdings (8)

StockWt% in HDFC Pharma and HealthcareWt% in NIPPON INDIA MULTI CAP FUND (MOverlap
Lupin Limited
Pharmaceuticals & Biotechnology
1.14%6.44%1.14%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
0.84%8.38%0.84%
Vijaya Diagnostic Centre Limited
Healthcare Services
0.82%2.30%0.82%
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
0.68%2.09%0.68%
Gland Pharma Limited
Pharmaceuticals & Biotechnology
0.53%1.12%0.53%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
0.46%6.21%0.46%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
0.39%4.80%0.39%
Dr. Lal Path Labs Limited
Healthcare Services
0.39%1.63%0.39%

Unique to HDFC Pharma and Healthcare

  • Sun Pharmaceutical Industries Ltd.9.81%
  • Glenmark Pharmaceuticals Ltd.6.62%
  • Max Healthcare Institute Limited6.36%
  • Aster DM Healthcare Limited5.42%
  • Anthem Biosciences Limited4.46%
  • Fortis Healthcare Limited4.02%

Unique to NIPPON INDIA MULTI CAP FUND (M

  • HDFC Bank Limited5.69%
  • ICICI Bank Limited4.37%
  • Axis Bank Limited3.85%
  • GE Vernova T&D India Limited3.04%
  • Infosys Limited2.54%
  • Max Financial Services Limited2.48%
  • NTPC Limited2.24%
  • Reliance Industries Limited2.21%
  • Linde India Limited2.02%
  • Larsen & Toubro Limited1.93%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
4.0% (6)
Healthcare Services
1.2% (2)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Pharma and Healthcare

More comparisons for NIPPON INDIA MULTI CAP FUND (M

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.